Li, H.-H.; Liu, X.; Wang, Y.-P.; Xu, X.; Zhu, L.; Zhang, W.; Ren, K.
Atractylenolide I Inhibits Nicotine-Induced Macrophage Pyroptosis and Alleviates Atherogenesis by Suppressing the TLR4/ROS/TXNIP/NLRP3 Pathway. Metabolites 2025, 15, 329.
https://doi.org/10.3390/metabo15050329
AMA Style
Li H-H, Liu X, Wang Y-P, Xu X, Zhu L, Zhang W, Ren K.
Atractylenolide I Inhibits Nicotine-Induced Macrophage Pyroptosis and Alleviates Atherogenesis by Suppressing the TLR4/ROS/TXNIP/NLRP3 Pathway. Metabolites. 2025; 15(5):329.
https://doi.org/10.3390/metabo15050329
Chicago/Turabian Style
Li, Huan-Huan, Xian Liu, Yu-Ping Wang, Xi Xu, Lin Zhu, Wei Zhang, and Kun Ren.
2025. "Atractylenolide I Inhibits Nicotine-Induced Macrophage Pyroptosis and Alleviates Atherogenesis by Suppressing the TLR4/ROS/TXNIP/NLRP3 Pathway" Metabolites 15, no. 5: 329.
https://doi.org/10.3390/metabo15050329
APA Style
Li, H.-H., Liu, X., Wang, Y.-P., Xu, X., Zhu, L., Zhang, W., & Ren, K.
(2025). Atractylenolide I Inhibits Nicotine-Induced Macrophage Pyroptosis and Alleviates Atherogenesis by Suppressing the TLR4/ROS/TXNIP/NLRP3 Pathway. Metabolites, 15(5), 329.
https://doi.org/10.3390/metabo15050329